123 results
Page 3 of 7
424B5
51yfgzf0 fp4ro5yiv8
16 Feb 21
Prospectus supplement for primary offering
6:03am
8-K
EX-1.1
tapd6dadpo24
27 Nov 20
Hepion Pharmaceuticals Prices Public Offering
1:48pm
8-K
EX-99.1
rqz8a44 ia1elubd
5 Aug 20
Hepion Pharmaceuticals Announces First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial
9:18am
424B5
3d8gai5
26 Mar 20
Prospectus supplement for primary offering
9:33pm
424B5
ky66184hgc i1
12 Feb 20
Prospectus supplement for primary offering
9:05am
424B4
00txtvy
19 Jun 19
Prospectus supplement with pricing info
5:25pm